The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

The Health and Human Services (HHS) Secretary named eight hand-picked members of the Advisory Committee on Immunisation ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

Alpha-1 is a microcosm of the rare disease world. The challenges we face, late diagnoses, inconsistent care, and unaffordable ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

Describing the current treatment landscape for primary and secondary bone cancer, Romness explains the potential of their own ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing ...